Shopping Cart
- Remove All
Your shopping cart is currently empty
Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $123 | 35 days |
| Description | Bifeprunox is a partial dopamine and serotonin agonist potentially for the treatment of schizophrenia. Bifeprunox suppresses in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation. Bifeprunox influences nicotine-seeking behaviour in response to drug-associated stimuli in rats. |
| Synonyms | DU-127090, DU127090, DU 127090, Bifeprunox |
| Molecular Weight | 481.56 |
| Formula | C25H27N3O5S |
| Cas No. | 350992-13-1 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.